CLINICAL_TRIALS
trial_result
· 2013-08-23
Clinical Trial Update: Gleevec Study for Patients With Ovarian Cancer [Phase 2]
Summary
Phase 2 trial of imatinib (Gleevec) in patients with ovarian cancer has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-08-23